BPL-003 is Beckley Psytech’s novel patent-protected benzoate salt formulation of 5-MeO-DMT that is administered intranasally. BPL-003 was shown to be safe and well-tolerated with a predictable ...

NEW YORK, and AMSTERDAM and OXFORD, United Kingdom, July 01, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company on a mission to develop ...

The webcast for the fireside chat will be available on atai’s website under Events on the Investors section of the atai website: https://ir.atai.life/news-events ...

A webcast of the company’s fireside chat will be available on atai’s website under Events on the Investors section of the atai website: https://ir.atai.life/news ...

Eli Lilly is nearing an agreement involving AtaiBeckley, Bloomberg reported on Wednesday, citing people familiar with the matter.

In case you aren't familiar, Atai is a biotech that's developing a handful of mental health treatments based on psychedelic molecules like MDMA via several subsidiaries and variable-interest entities.

Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited peer ...

In the creation story of the Nigerian Efik people, the creator god Abassi and his goddess wife find themselves in a disagreement over where humans should live. While Abassi desires for humans to live ...